Stroke | Fluoxetine for Motor, Aphasia, and Neglect Recovery After Ischemic Stroke

Stroke research study

What is the primary objective of this study?

This pilot study will recruit 25 subjects to assess the feasibility of replicating the FLAME study (Chollet, et al. Lancet 2011), a randomized controlled trial (RCT) that assessed the effect of fluoxetine vs placebo on motor recovery after ischemic stroke, in an American sample of post-acute stroke patients. This trial will in addition examine the effect of treatment with fluoxetine versus placebo on concurrent deficits in language and hemispatial attention, as well as post-stroke fatigue and will evaluate the durability of observed effects. The results of this pilot trial will be used to develop power estimates for a larger trial and to evaluate recruitment and intervention completion rates for subjects in an American post-acute environment. There are two additional substudies: the first will use MRI to assess structural changes at the beginning and end of the intervention; the second will examine the relationship of serum biomarkers of inflammation to the intervention.

Who is eligible to participate?

Inclusion Criteria: - Ischemic infarction within 15 days - Admission NIHSS item 5 score equal to or >2 -Able to give informed consent, with surrogate consent acceptable- Exclusion Criteria: - Pre-stroke modified Rankin Scale score equal or .3 - Pregnant or lactating - Taking an SSRI on admission to SRH - Taking a medication likely to have adverse interaction with an SSRI - Unable to return for follow-up testing days 90,180 - Concurrent medial condition likely to worsen patient's functional status over next 6 months - Unable to competently participate in testing for 45min-2hrs with rest breaks - for MRI substudy: contraindication to MRI

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?


Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Drug:fluoxetine20 mg daily for 90 days starting day 5-10 after stroke.

Drug:placebosubjects will take one pill po daily for 90 days.

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

FluoxetineSubjects will take 20 mg fluoxetine daily for 90 days after stroke

placeboSubjects will take one pill daily for 90 days after stroke.

Study Status


Start Date: April 2013

Completed Date: December 2015

Phase: N/A

Type: Interventional


Primary Outcome: Fugl-Meyer Motor Scale (FMMS)

Secondary Outcome: Western Aphasia Battery

Study sponsors, principal investigator, and references

Principal Investigator:

Lead Sponsor: Spaulding Rehabilitation Hospital


More information:

Discuss Prozac